Search Ontology:
ChEBI
TW-37
- Term ID
- CHEBI:95008
- Synonyms
-
- N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide
- N-[4-[[2-(1,1-dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]-benzamide
- N-{4-[(2-tert-butylphenyl)sulfonyl]phenyl}-2,3,4-trihydroxy-5-[2-(propan-2-yl)benzyl]benzamide
- TW 37
- TW37
- Definition
- A secondary carboxamide resulting from the formal condensation of the carboxy group of 2,3,4-trihydroxy-5-[2-(propan-2-yl)benzyl]benzoic acid with the amino group of 4-[(2-tert-butylphenyl)sulfonyl]aniline. It is a potent inhibitor of Bcl-2 family of proteins (Ki = 260, 290 and 1110 nM for Mcl-1, Bcl-2 and Bcl-xL).
- References
-
- CAS:877877-35-5
- DrugBank:DB17059
- LINCS:LSM-6236
- PMID:16951185
- PMID:17404107
- PMID:18528859
- PMID:19220884
- PMID:19318573
- PMID:19372562
- PMID:20675079
- PMID:23832116
- PMID:25823945
- PMID:26958630
- PMID:28696828
- PMID:29065135
- PMID:29207200
- PMID:29631678
- PMID:30885150
- PMID:31052354
- PMID:32079453
- PMID:32163813
- PMID:32257914
- PMID:32863764
- PMID:33568941
- PMID:33951465
- PMID:36907299
- PMID:37385390
- PMID:37582646
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from TW-37
Phenotype where environments contain TW-37
Phenotype modified by environments containing TW-37
Human Disease Model